Results 161 to 170 of about 2,400 (204)
Some of the next articles are maybe not open access.

Related searches:

Avoidance facilitation by nootropics

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1989
1. The effects on avoidance acquisition of two nootropic drugs, oxiracetam and piracetam, were tested in mice subjected to five daily 100-trial training sessions in the shuttle-box. 2. Oxiracetam (25 or 50 mg/kg/i.p.) and piracetam (100 mg/kg/i.p.), given before each daily session, improved avoidance acquisition in the good performing BALB/c more than ...
M, Sansone, A, Oliverio
openaire   +2 more sources

Towards Better Brain Management: Nootropics

Current Medicinal Chemistry, 2007
The learning and memory deficits have been recognized as severe and consistent neurological disorders associated with numerous neurodegenerative states. Research in this area has gained momentum only in the recent past after the biochemical and physiological basis of these processes have been understood.
Ruchi, Malik   +4 more
openaire   +2 more sources

Nootropics

2002
Abstract The term ‘nootropics’ (from Greek, noos—mind, tropos—turn) was originally coined to denote chemical compounds that were reported to enhance cognitive function, including learning and memory, without possessing other significant effects (Giurgea 1973). The best known are piracetam and structurally related compounds (Giurgea 1973;
openaire   +1 more source

Nootropics And Foods

1999
Food, diet, vitamins, trace elements, minerals, and additives have been part of folk treatments for mental disorders dating back to itinerant peddlers of snake oil. Foods are often touted by those outside the traditional medical mainstream as substitutes for established treatments.
C. Keith Conners, Elizabeth P. Sparrow
openaire   +1 more source

Piracetam and other structurally related nootropics

Brain Research Reviews, 1994
Nearly three decades have now passed since the discovery of the piracetam-like nootropics, compounds which exhibit cognition-enhancing properties, but for which no commonly accepted mechanism of action has been established. This review covers clinical, pharmacokinetic, biochemical and behavioural results presented in the literature from 1965 through ...
A H, Gouliaev, A, Senning
openaire   +2 more sources

Home - About - Disclaimer - Privacy